Patterson Companies Inc
F:PD2
Patterson Companies Inc
F:PD2
Price:
27.4
EUR
Market Closed
Market Cap:
€2.4B
Relative Value
The Relative Value of one
PD2
stock under the Base Case scenario is
42.52
EUR.
Compared to the current market price of 27.4 EUR,
Patterson Companies Inc
is
Undervalued by 36%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PD2
Relative Value
Base Case
42.52
EUR
Undervaluation 36%
Multiples Across Competitors
PD2 Competitors Multiples
Patterson Companies Inc Competitors
Patterson Companies Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Patterson Companies Inc
F:PD2
|
2.8B EUR | 0.4 | 20 | 11.2 | 16.3 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
117.1B USD | 0.3 | 29.1 | 20.4 | 23 | |
| US |
|
Cencora Inc
NYSE:COR
|
69.7B USD | 0.2 | 44.8 | 15.1 | 19.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.2B USD | 0.2 | 44.4 | 15 | 19.3 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
54.3B USD | 0.2 | 34.1 | 16.6 | 21.8 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36B AUD | 6 | 67.9 | 51.2 | 51.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.8B CNY | 1.5 | 17.5 | 13.5 | 13.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY | 0.2 | 11.4 | 15.3 | 15.3 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD | 0.7 | 24.1 | 11.5 | 16.1 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD | 0.1 | 8.6 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
